Clinical observation and management of COVID-19 patients
Loading...
Date
2020
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Taylor and Francis
Abstract
Three leading infectious disease experts in China were invited to share their bedside observations in the management of
COVID-19 patients. Professor Taisheng Li was sent to Wuhan to provide frontline medical care. He depicts the clinical
course of SARS-CoV-2 infection. Furthermore, he observes the significant abnormality of coagulation function and
proposes that the early intravenous immunoglobulin and low molecular weight heparin anticoagulation therapy are
very important. Professor Hongzhou Lu, a leader in China to try various anti-viral drugs, expresses concern on the
quality of the ongoing clinical trials as most trials are small in scale and repetitive in nature, and emphasizes the
importance of the quick publication of clinical trial results. Regarding the traditional Chinese medicine, Professor Lu
suggests to develop a creative evaluation system because of the complicated chemical compositions. Professor
Wenhong Zhang is responsible for Shanghai’s overall clinical management of the COVID-19 cases. He introduces the
team approach to manage COVID-19 patients. For severe or critically ill patients, in addition to the respiratory
supportive treatment, timely multiorgan evaluation and treatment is very crucial. The medical decisions and
interventions are carefully tailored to the unique characteristics of each patient.
Description
Keywords
Clinical management, antiviral drugs, SARS, SARS-CoV-2
Citation
Taisheng Li, Hongzhou Lu & Wenhong Zhang (2020) Clinical observation and management of COVID-19 patients, Emerging Microbes & Infections, 9:1, 687-690, DOI: 10.1080/22221751.2020.1741327